1. Home
  2. SNY

SNY

Sanofi ADS

Logo Sanofi ADS

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Founded: N/A Country:
France
France
Employees: N/A City: N/A
Market Cap: 115.4B IPO Year: N/A
Target Price: $55.00 AVG Volume (30 days): 2.0M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: 4.34% Dividend Payout Frequency: Annual
EPS: 2.29 EPS Growth: -13.13
52 Week Low/High: $42.63 - $57.82 Next Earning Date: 04-25-2024
Revenue: $51,604,444,444 Revenue Growth: 18.56%
Revenue Growth (this year): 2.3% Revenue Growth (next year): 7.05%

Share on Social Networks: